IP Library › Granted Patent US 10,221,194
Granted Patent B2
US 10,221,194 · App. 15/606,928 · Granted Mar 5, 2019

Quinazoline analogs as receptor tyrosine kinase inhibitors

Inventors: Eli Wallace (Richardson, TX); Joseph Lyssikatos (Piedmont, CA); George Topalov (Pittsburgh, PA); Alexandre Buckmelter (Westford, MA); Qian Zhao (El Cerrito, CA)
Assignee: Array BioPharma Inc.
C07D498/10C04B35/632C07D239/94C07D401/12C07D413/12C07D413/14C07D417/14C07D498/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,221,194
App. No.
15/606,928
Granted
Mar 5, 2019
Kind
B2
Abstract

The invention relates to compounds of Formula 11, and to pharmaceutically acceptable acid addition salts thereof, wherein R 1 —R 3 , R 6 , and X have any of the values defined in the specification. The compounds are suitable as synthetic intermediates for preparing imaging tools.

Claims (1)

1. A compound selected from the group consisting of:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: WALLACE, ELI; TOPALOV, GEORGE; LYSSIKATOS, JOSEPH; BUCKMELTER, ALEXANDRE; ZHAO, QIAN
To: ARRAY BIOPHARMA INC.
Reel/Frame 047519/0234 →
Continuity (6)
Continuation 13607016 · Sep 7, 2012
Continuation 12249421 · Oct 10, 2008
Division 10914974 · Aug 10, 2004
Continuation In Part 10642440 · Aug 14, 2003
Provisional Application 60551718 · Mar 10, 2004
Related Publication 20170260202A1 · Sep 14, 2017